TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17534584

Group type: EXPERIMENTAL
Intervention: Induced normothermia (IN) with automated surface cooling system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-shivering patients
Number of subjects: 24
Study: 15037323

Group type: EXPERIMENTAL
Intervention: Gatifloxacin (400 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ciprofloxacin (500 mg)
Number of subjects: 12
Study: 11442611

Group type: EXPERIMENTAL
Intervention: Long-pulsed alexandrite laser (755 nm, 2‐msec pulse, 10 mm spot) at 25 J/cm2 or 40 J/cm2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Long-pulsed diode laser (800 nm, 12.5 msec or 25 msec, 9 mm spot) at 25 J/cm2 or 40 J/cm2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-pulsed diode laser at 40 J/cm2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-pulsed alexandrite laser
Number of subjects: 20
Study: 9929929

Group type: EXPERIMENTAL
Intervention: Diet with increased omega-3 PUFA in addition to ibuprofen treatment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no omega-3 PUFA diet, only ibuprofen)
Number of subjects: 23
Study: 8306366

Group type: EXPERIMENTAL
Intervention: IL‐2 i.a. infusion for 4 days (Group A, n = 3)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IFN alpha s.c. for 5 days followed by continuous IL‐2 i.v. infusion for 5 days (Group B, n = 4)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: IL‐2 i.v. infusion for 4 days with s.c. IFN alpha on days 1 and 4 (Group C, n = 4)
Number of subjects: 11
Study: 3378553

Group type: EXPERIMENTAL
Intervention: Atropine sulphate 1.25 micrograms kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.75 micrograms kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atropine sulphate 2.5, 2.5 and 5 micrograms kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 1.5, 1.5 and 3.0 micrograms kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atropine sulphate (same dose as Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (same dose as Group 2)
Number of subjects: 40
Study: 30557034

Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 60
Study: 27922270

Group type: EXPERIMENTAL
Intervention: Brief behavioral intervention
Number of subjects: 407

Group type: COMPARATOR
Intervention: Attention placebo control
Number of subjects: 407
Study: 26698303

Group type: EXPERIMENTAL
Intervention: 800 IU ergocalciferol daily until delivery
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Single oral bolus of 200,000 IU cholecalciferol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no Vitamin D)
Number of subjects: 180
Study: 24025658

Group type: EXPERIMENTAL
Intervention: Medicare Part D prescription drug plan (PDP) with covered drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medicare Part D prescription drug plan (PDP) with noncovered drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prior authorization or step therapy for covered drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medicare Part D prescription drug plan (PDP)
Number of subjects: 0
Study: 20422423

Group type: EXPERIMENTAL
Intervention: 600 μg misoprostol orally
Number of subjects: 658

Group type: COMPARATOR
Intervention: 600 μg misoprostol rectally
Number of subjects: 658
Study: 18708842

Group type: EXPERIMENTAL
Intervention: Toe sponges application for 3 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no toe sponges)
Number of subjects: 24
Study: 16779765

Group type: EXPERIMENTAL
Intervention: Playing mahjong twice a week (n = 33)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Playing mahjong four times a week (n = 29)
Number of subjects: 62
Study: 12707981

Group type: EXPERIMENTAL
Intervention: Creatine (3 g daily for 3 months)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Maltodextrin (placebo)
Number of subjects: 15
Study: 10946888

Group type: EXPERIMENTAL
Intervention: Continuous GH treatment at 33 microg/kg x day
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Continuous GH treatment at 67 microg/kg x day
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Discontinuous GH treatment (average dose 32 microg/kg x day over 6 yr)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 188
Study: 8793161

Group type: EXPERIMENTAL
Intervention: Stable angina patients (male)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Stable angina patients (female)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Female patients with clinical heart failure
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Female patients without clinical heart failure
Number of subjects: 675

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: Angina patients
Number of subjects: 675
Study: 1451716

Group type: EXPERIMENTAL
Intervention: Captopril 50 mg b.d.
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg o.d.
Number of subjects: 77
Study: 6207197

Group type: EXPERIMENTAL
Intervention: Antithyroid drug and T4 (group I)
Number of subjects: 21

Group type: COMPARATOR
Intervention: β1‐selective adrenoreceptor blocking agent metoprolol (group II)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Euthyroid patients (group III)
Number of subjects: 21
Study: 31638902

Group type: EXPERIMENTAL
Intervention: Namaste Care intervention
Number of subjects: 20
Study: 30592442

Group type: EXPERIMENTAL
Intervention: Unskilled model observation combined with motor imagery training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Skilled model observation combined with motor imagery training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (reading a scientific paper)
Number of subjects: 36
Study: 26970852

Group type: EXPERIMENTAL
Intervention: Partial sialoadenectomy (PS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Total sialoadenectomy (TS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both PS and TS
Number of subjects: 31
Study: 24621019

Group type: EXPERIMENTAL
Intervention: Peak wheelchair exercise test measuring POpeak (power output)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Peak wheelchair exercise test measuring VO2peak (oxygen uptake)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Life satisfaction measurement
Number of subjects: 225
Study: 22196428

Group type: EXPERIMENTAL
Intervention: Traditional Thai massage (TTM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Physical therapy modalities (PT: ultrasound therapy and hot pack)
Number of subjects: 20
Study: 20470840

Group type: EXPERIMENTAL
Intervention: Sucrose sweetened soft drinks (4x25cl per day; 1800kJ)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Aspartame sweetened soft drinks (4x25cl per day; 67kJ)
Number of subjects: 53
Study: 17909308

Group type: EXPERIMENTAL
Intervention: Selegiline ODT (1.25 mg/d for 6 weeks, then 2.5 mg/d for 6 weeks)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Selegiline ODT
Number of subjects: 148
Study: 14979606

Group type: EXPERIMENTAL
Intervention: Vascor (test formulation of simvastatin 10 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Commercially available preparation (reference formulation of simvastatin 10 mg)
Number of subjects: 18
Study: 12201587

Group type: EXPERIMENTAL
Intervention: ARILVAX
Number of subjects: 1440

Group type: COMPARATOR
Intervention: YF-VAX
Number of subjects: 1440

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 1440
Study: 9524624

Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution rinsing 4 times daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sterile water rinsing (Control)
Number of subjects: 40
Study: 8590895

Group type: EXPERIMENTAL
Intervention: Liposomal melanoma vaccine combined with low-dose regional IL-2 (arm C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose regional IL-2 only (arm D)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Liposomal melanoma vaccine alone (arm A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Liposomal melanoma vaccine combined with systemic IL-2 (arm B)
Number of subjects: 24
Study: 2666454

Group type: EXPERIMENTAL
Intervention: Diltiazem (120 mg bid to 180 mg bid)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 404027

Group type: COMPARATOR
Intervention: Extended field irradiation alone
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Limited field irradiation followed by MOPP chemotherapy
Number of subjects: 74
Study: 30636974

Group type: EXPERIMENTAL
Intervention: Digital supply chain
Number of subjects: 57

Group type: COMPARATOR
Intervention: Traditional supply chain
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both supply chains
Number of subjects: 57
Study: 30192681

Group type: EXPERIMENTAL
Intervention: Progressive hop‐to‐stabilization balance (PHSB) program
Number of subjects: 18

Group type: COMPARATOR
Intervention: Single-limb balance (SLB) program
Number of subjects: 18
Study: 26806185

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1500mg once daily)
Number of subjects: 407

Group type: COMPARATOR
Intervention: No DEP + placebo (Control)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: DEP + placebo (DEP)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: DEP + glucosamine sulfate (DEP + GS)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate + no DEP (GS)
Number of subjects: 407
Study: 25561135

Group type: EXPERIMENTAL
Intervention: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily) plus coenzyme Q10 (4 capsules of 30 mg/capsule, daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21844282

Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation treatment (IRT) - 4 weeks of inpatient physical therapy including treadmill and stabilometric platform training.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group received only pharmacological treatment and was invited to practice generic physical exercise at home.
Number of subjects: 50
Study: 20633256

Group type: COMPARATOR
Intervention: Education and advice session with a physiotherapist based on the content of the 'Back Book'
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Education and advice session plus a graded pedometer-driven walking programme prescribed by the physiotherapist
Number of subjects: 50
Study: 17467956

Group type: EXPERIMENTAL
Intervention: Dihydrexidine (20 mg subcutaneously)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15684319

Group type: EXPERIMENTAL
Intervention: Dietary counseling (regular foods)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Protein supplements
Number of subjects: 111

Group type: COMPARATOR
Intervention: Ad libitum intake
Number of subjects: 111
Study: 12148107

Group type: EXPERIMENTAL
Intervention: Daily short hemodialysis (DHD; six 2-hour sessions per week)
Number of subjects: 14
Study: 10440307

Group type: EXPERIMENTAL
Intervention: ORS with reduced osmolarity
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard WHO ORS
Number of subjects: 300
Study: 8773035

Group type: EXPERIMENTAL
Intervention: 40 mg Ginkgo biloba extract at 6 hourly intervals along with routine management
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo tablets of same size, shape and colour, given in the same way as Ginkgo biloba
Number of subjects: 55
Study: 2405893

Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine (Scopoderm, Ciba‐Geigy)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study: 6161281

Group type: EXPERIMENTAL
Intervention: Combined treatment modality (vitrectomy plus photocoagulation)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sole application of photocoagulation
Number of subjects: 28
Study: 30312457

Group type: EXPERIMENTAL
Intervention: Observed height
Number of subjects: 14676

Group type: EXPERIMENTAL
Intervention: Height genetic score
Number of subjects: 14676

Group type: EXPERIMENTAL
Intervention: Observed BMI
Number of subjects: 14676

Group type: EXPERIMENTAL
Intervention: BMI genetic score
Number of subjects: 14676
Study: 27221151

Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa (HS)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 78

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 78
Study: 26310300

Group type: COMPARATOR
Intervention: Point-to-point irrigated radiofrequency ablation (Conv)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Phased multipolar radiofrequency ablation (PMRA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall success rate for zero AF recurrence at 12 months
Number of subjects: 50
Study: 25218696

Group type: EXPERIMENTAL
Intervention: Nocturnal denture wear
Number of subjects: 70

Group type: COMPARATOR
Intervention: No denture wear
Number of subjects: 70
Study: 21975269

Group type: EXPERIMENTAL
Intervention: Hormonal contraception (injectable and oral)
Number of subjects: 3790

Group type: COMPARATOR
Intervention: No hormonal contraception
Number of subjects: 3790
Study: 20216558

Group type: EXPERIMENTAL
Intervention: High-protein low-fat diet (HP-LF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-protein high-fat diet (LP-HF)
Number of subjects: 17
Study: 17924243

Group type: EXPERIMENTAL
Intervention: Web-based bipolar education program
Number of subjects: 8000
Study: 15832145

Group type: EXPERIMENTAL
Intervention: Weekly physiotherapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no physiotherapy)
Number of subjects: 43
Study: 12077724

Group type: EXPERIMENTAL
Intervention: Low-glycemic index breakfast (low-GIB)
Number of subjects: 13

Group type: COMPARATOR
Intervention: High-glycemic index breakfast (high-GIB)
Number of subjects: 13
Study: 10345258

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention to improve preventive services
Number of subjects: 647
Study: 7881957

Group type: EXPERIMENTAL
Intervention: Graduated compression hosiery (various brands)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pneumatic thigh cuffs inflated to 20 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pneumatic thigh cuffs inflated to 40 mmHg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Custom-made stockings with a profile of 16.8 mmHg at the ankle, 14.5 mmHg at the calf, and 6.4 mmHg at the upper thigh
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard compression profile stockings (18 mmHg at the ankle, 14 mmHg at the calf, and 8 mmHg at the upper thigh)
Number of subjects: 0
Study: 2194788

Group type: EXPERIMENTAL
Intervention: Fenugreek seeds (100 g, divided into two doses during lunch and dinner)
Number of subjects: 0
Study: 7393831

Group type: EXPERIMENTAL
Intervention: Intravenous naloxone administration
Number of subjects: 0
Study: 30292847

Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 96

Group type: COMPARATOR
Intervention: CE-CT
Number of subjects: 96
Study: 29232438

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 297

Group type: COMPARATOR
Intervention: CHOP without MYC translocations
Number of subjects: 297

Group type: COMPARATOR
Intervention: CHOP with negative MYC-IHC
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Rituximab as part of salvage therapy
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Rituximab after first-line CHOP
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Rituximab after R-CHOP
Number of subjects: 297
Study: 26384447

Group type: EXPERIMENTAL
Intervention: TDV (various dosages including increased TDV-4 and one-tenth TDV dose)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 140
Study: 23124684

Group type: EXPERIMENTAL
Intervention: Evidence-based supported employment
Number of subjects: 187

Group type: COMPARATOR
Intervention: Diversified placement approach
Number of subjects: 187
Study: 20840689

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus oral hygiene instruction
Number of subjects: 322

Group type: COMPARATOR
Intervention: Oral hygiene instruction only (control)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Successful periodontal treatment
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Unsuccessful periodontal treatment
Number of subjects: 322
Study: 19166685

Group type: EXPERIMENTAL
Intervention: Elevated leukocyte counts after primary PCI
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Elevated neutrophil counts after primary PCI
Number of subjects: 363
Study: 17547876

Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 0
Study: 16389542

Group type: EXPERIMENTAL
Intervention: 5 mg Delta(9)-tetrahydrocannabinol (dronabinol)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12587799

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 60
Study: 10917981

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted abdominal aortic aneurysmectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open transabdominal or retroperitoneal aneurysmectomy
Number of subjects: 60
Study: 8806339

Group type: EXPERIMENTAL
Intervention: Active pectoral-pulse generator shell
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lead alone (control)
Number of subjects: 21
Study: 1634627

Group type: EXPERIMENTAL
Intervention: Occlusal Adjustment (OA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No Occlusal Adjustment (No OA)
Number of subjects: 50
Study: 6480247

Group type: EXPERIMENTAL
Intervention: Conditioned emotional response established with a specific tone pattern followed by an aversive noise in the left ear.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects received noises presented at random times without a specific tone pattern.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental subjects on interpolated CS-alone trials.
Number of subjects: 0
Study: 31199501

Group type: EXPERIMENTAL
Intervention: TP53 mutations
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: TP53 and either KRAS or NRAS mutations
Number of subjects: 210

Group type: COMPARATOR
Intervention: BRAF mutation
Number of subjects: 210
Study: 31438908

Group type: EXPERIMENTAL
Intervention: Time-limited letter with pre-notification and reminder SMS
Number of subjects: 12244

Group type: EXPERIMENTAL
Intervention: Open-ended letter with reminder SMS
Number of subjects: 12244

Group type: EXPERIMENTAL
Intervention: Time-limited letter with reminder SMS
Number of subjects: 12244

Group type: COMPARATOR
Intervention: Control letter without SMS
Number of subjects: 12244
Study: 29166194

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 44
Study: 26939313

Group type: EXPERIMENTAL
Intervention: Acupuncture for warming yang and benefiting qi
Number of subjects: 180

Group type: COMPARATOR
Intervention: Seretide (western medication)
Number of subjects: 180
Study: 22907998

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) with cooling gel packs to a target temperature of 33‐34°C for 72 h
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Normothermia (Control)
Number of subjects: 116
Study: 21212385

Group type: EXPERIMENTAL
Intervention: 20 Gy of radiation therapy (TE18 trial)
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Carboplatin (TE19 trial)
Number of subjects: 2466

Group type: EXPERIMENTAL
Intervention: Para‐aortic radiation therapy (TE10 trial)
Number of subjects: 2466

Group type: COMPARATOR
Intervention: Radiation therapy (TE19 trial)
Number of subjects: 2466
Study: 18372441

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antiplatelet therapy
Number of subjects: 0
Study: 16705841

Group type: EXPERIMENTAL
Intervention: Acu-moxibustion group (treated with filiform needle plus moxibustion)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Basic treatment plus acu-moxibustion group (treated with oral medicine like those in the control group plus acupuncture and moxibustion)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group (treated with prednisone, vitamin B1, vitamin B12 and dibazol)
Number of subjects: 480
Study: 15353914

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No ANH
Number of subjects: 71
Study: 11397789

Group type: EXPERIMENTAL
Intervention: Preeclampsia plasma
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal pregnancy plasma
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonpregnant women plasma
Number of subjects: 21
Study: 9242312

Group type: EXPERIMENTAL
Intervention: Clinical signs and laboratory parameters (cold periphery, deep coma, hypoglycemia)
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Elevated urea levels on admission, multiple episodes of hypoglycemia, multiple convulsions
Number of subjects: 624
Study: 8098238

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms twice daily)
Number of subjects: 3516

Group type: COMPARATOR
Intervention: Salbutamol (200 micrograms four times a day)
Number of subjects: 3516

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 3516

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 3516

Group type: EXPERIMENTAL
Intervention: Salmeterol and Salbutamol
Number of subjects: 3516
Study: 3327022

Group type: EXPERIMENTAL
Intervention: Vincristine combination therapy (COP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vindesine combination therapy (CEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vincristine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vindesine
Number of subjects: 0
Study: 31990954

Group type: EXPERIMENTAL
Intervention: Treadmill workstation intervention
Number of subjects: 20
Study: 28730676

Group type: EXPERIMENTAL
Intervention: Intranasal glucagon (ING) 1 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intranasal placebo (INP)
Number of subjects: 10
Study: 26512029

Group type: EXPERIMENTAL
Intervention: High knowledge scores
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: High practice scores
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Moderate knowledge and practice scores
Number of subjects: 423